Anna Thorisdottir

Prevalence Severity | Protease Inhibitor | Hiv1 Infection | Oral Glucose Tolerance | Longterm Therapy

Prominent publications by Anna Thorisdottir

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

[ PUBLICATION ]

KOL Index score: 11410

BACKGROUND: The prevalence and severity of lipodystrophy syndrome with long-term therapy for HIV-1 infection that includes a protease inhibitor is unknown. We studied the natural course of the syndrome to develop diagnostic criteria and identifying markers that predict its severity.

METHODS: We assessed 113 patients who were receiving HIV-1 protease inhibitors (mean 21 months) and 45 HIV-1-infected patients (28 with follow-up) never treated with a protease inhibitor. Lipodystrophy was ...

Also Ranks for: Diabetes Mellitus | physical examination | protease inhibitor | prevalence severity | therapy hiv1

Key People For Prevalence Severity

Top KOLs in the world

Ronald * *******

mental disorders united states major depression

Douglas * *******

observational studies consort statement randomised trials

Neil * ******

new zealand global burden lung cancer

David ***** ********

lung function international study air pollution

Aubrey *******

dental caries oral health periodontal disease

Christopher * * ******

global burden life expectancy united states

Select a search phrase prevalence severity , prevalence severity illness , prevalence severity anemia , prevalence severity anxiety , prevalence severity cad

Anna Thorisdottir:Expert Impact

Concepts for whichAnna Thorisdottirhas direct influence:Prevalence severity, Protease inhibitor, Lipodystrophy severity, Inhibitor therapy, Severity lipodystrophy, Inhibitor lipodystrophy, Hiv1 infection, Hiv1 protease inhibitors.

Anna Thorisdottir:KOL impact

Concepts related to the work of other authors for whichfor which Anna Thorisdottir has influence:Antiretroviral therapy, Hiv infection, Insulin resistance, Protease inhibitors, Human immunodeficiency virus, Infected patients, Highly active.

Tools

Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile https://www.keyopinionleaders.com/Prevalence-Severity/Anna-Thorisdottir-Hiv-Medicine-Unit-And-Centre-For-Immunol-81307f57db1a727cea82044209331cc3-rl.html

HIV Medicine Unit and Centre for Immunology, St Vincent's Hospital, Sydney, NSW 2010, Australia